Patents Represented by Attorney Matthew Bruce Zisk
  • Patent number: 6984647
    Abstract: This invention is directed to vanilloid receptor VR1 ligands. More particularly, this invention relates to ?-aminotetralin-derived ureas that are potent antagonists or agonists of VR1 which are useful for the treatment and prevention of inflammatory and other pain conditions in mammals.
    Type: Grant
    Filed: May 15, 2003
    Date of Patent: January 10, 2006
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Scott L. Dax, Michele Jetter, Mark McDonnell, James J. McNally, Mark Youngman